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1. INTRODUCTION 
It is known that the primary event of insulin ac- 
tion is the binding of insulin to a specific cell surfa- 
ce receptor [l]. Following binding, insulin com- 
plexed with its receptor is aggregated into patches 
and internalized by endocytosis [2,3]. Eventually, 
the endocytotic vesicles fuse with lysosomes where 
insulin is degraded. Whether this insulin proces- 
sing is necessary for insulin action and if so exactly 
how it leads to the stimulation of cellular metabo- 
lism remains unknown. There have been suggesti- 
ons that the interaction of insulin with its receptor 
somehow generates a second, intracellular messen- 
ger [4-61. Yet, despite an extensive search, a mes- 
senger which can account for all of insulin’s diver- 
se activities has not been identified. 
As a step toward understanding the functional 
significance of the internalized insulin we devised 
a delivery system of insulin into cells bypassing the 
insulin receptor. In this paper, we describe the syn- 
thesis of a hybrid molecule in which insulin is 
cross-linked to a human serum protein, 
cuz-macroglobulin (a2M). Evidence is presented to 
show that insulin is internalized through a2M 
receptor-mediated endocytosis and -delivered to 
lysosome-like dense organelles in the form of 
conjugate. 
2. MATERIALS AND METHODS 
Mouse Swiss/3T3 cells and CI-3 cells were 
grown in Dulbecco’s modified Eagle medium 
(DME-medium) supplemented with 10% fetal calf 
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Cross-linking of [1251]insulin with a2M was per- 
formed by the method using cystamine [lo]. Brief- 
ly, porcine insulin (Eli Lilly, 10 mg) was dissolved 
in 5 ml of 0.01 N HCl and cystamine dihydrochlo- 
ride (Sigma, 1.13 g) was added. 1-ethyl-3-(3-dime- 
thyl-aminopropyl) carbodiimide HCl (EDAC, 
3.83 mg) was added and the pH was maintained at 
4.7 for 10 min with gentle stirring. The reaction 
was stopped by adjusting the pH to 8.8 with 10 N 
NaOH and 2 ml of reaction mixture were applied 
onto a column (1.6 x 18 cm) of Biogel P4, which 
was equilibrated with 10 mM N-Tris (hydroxy- 
methyl) methyl-2-aminomethane sulfonic acid, pH 
8.8, to remove unreacted cystamine 
dihydrochloride and EDAC. The purified 
cystaminyl insulin (11.2 pg) was reacted with 
1 mCi of “‘1 using chloramine-T (0.16 pug) in a 
total reaction volume of 30~1. After 2 min at 
room temperature, tyrosine (8 pg) was added to 
stop further iodination and the reaction mixture 
was kept overnight at 4°C. The mixture was then 
incubated with a2M (2OOpg) for 2 h at 4°C to 
allow formation of spontaneous disulfide bonds. 
Molar ratio of insulin/cr2M was 7. The reaction 
mixture was then applied on a column of Sephadex 
G-100 equilibrated with 30 mM Na-phosphate buf- 
fer (pH 7.5) containing 0.1 M NaCl. A radioactivi- 
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cr2-Macroglobulin Percoll gradient Lysosomes 
serum (FCS), 100 units/ml penicillin, and 
100 pg/ml streptomycin as described before [7]. 
cuz-Macroglobulin (cu2M) was prepared from hu- 
man plasma according to the published method 
[8]. CY~M was iodinated by the chloramine-T me- 
thod [9]. The specific activity of [‘251]~2M was 
0.7 &i/pg. 
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ty peak which eluted at the void volume was col- 
lected. The specific activity of [1251]insulin-a2M 
conjugate was 0.5 ,uCi/,ug protein. 
Binding assay was carried out as described befo- 
re [7]. Briefly, cells grown to confluency in 35mm 
tissue culture dishes were washed twice with 1 ml 
of binding buffer, consisting of 100 mM Hepes at 
pH 7.8, 100 mM NaCl, 1.2 mM MgS04, 5 mM 
KCl, 10 mM glucose, 1 mM EDTA, 15 mM sodi- 
um acetate, and 0.1% bovine serum albumin 
(BSA, Sigma, RIA grade). Then, the cells were in- 
cubated with iodinated a2M (2 nM), insulin 
(0.27 nM) or conjugate (1.6 nM) at 23°C for the 
appropriate time. The cells were placed on ice and 
rinsed 3 times with ice-cold binding buffer. The 
cells were solubilized in 0.5 N NaOH and the radi- 
oactivity was measured in a Beckman 4000 gamma 
counter. To determine nonspecific binding, unla- 
belled cu2M (500 nM), insulin (3 /cM) or both of 
these ligands was added before the addition of the 
radioactive ligands. Nonspecific binding was sub- 
tracted from total binding to get specific binding. 
Percoll density gradient fractionation was per- 
formed as previously described [l 11. Binding of 
Fig.1. Analysis of [‘251]insulin-cY2M conjugate by 
Sephadex G-75 column. Conjugates were treated with 
10 mM dithiothreitol (0) or not (0) and subjected to gel 
filtration on Sephadex G-75 equilibrated with 4 M urea, 
1 M acetic acid and 0.1% Triton X-100. Intact and 
reduced insulin were eluted at positions 1 and 2, 
respectively. VO, void volume. 
[‘251]conjugate o the confluent cells in lOO-mm 
dishes was carried out at 23°C as detailed above. 
After 90 min incubation, cultures were washed 3 
times with binding buffer. Some cultures were fur- 
ther incubated at 37°C in 8 ml of DME-medium 
containing 10% FCS for 30 min and rinsed twice 
with binding buffer. The cells were scraped from 
the dish in 10 ml of 0.25 M sucrose containing 
1 mM EDTA, 10 mM acetic acid and 10 mM tri- 
ethanolamine, pH 7.4 (SEAT buffer), and lysed by 
gentle pipetting. Nuclei and unbroken cells were 
pelleted by centrifugation at 800 rev./min for 
10 min and the post-nuclear supernatant (0.9 ml) 
was layered on a 9 ml suspension of 20% Percoll 
in SEAT buffer. A gradient was formed by centri- 
fugation at 16000 rev./min for 90 min with an 
SS34 rotor in a Sorvall RC-5B centrifuge. The gra- 
dient was displaced from the bottom. The density 
of the fractions was determined using an Abbe 
refractometer. 
Marker enzyme assays were performed as descri- 
bed before [I 11. These included UDP-galactose- 
glycoprotein galactosyl transferase (EC 2.4.1.38) 
for Golgi, acid phosphatase (EC 3.1.3.2) and ,&- 
galactosidase (EC 3.2.1.23) for lysosomes and 
NADPH cytochrome c reductase (EC 1.6.2.4) for 
endoplasmic reticulum. 
3. RESULTS 
[‘251]Insulin was cross-linked to a2M by the me- 
thod using cystamine as described in section 2. The 
conjugate was analyzed by Sephadex G-75 column 
chromatography (fig. 1). It is seen that a major ra- 
dioactivity peak was eluted at the void volume, in- 
dicating the formation of high molecular weight 
conjugates consisting of [“‘I]insulin (MI 6000) and 
a2M (Mr 725000). When the conjugate was treated 
with 10 mM dithiothreitol and analyzed on the sa- 
me column, the major radioactivity peak shifted to 
the position at which a- and P-chains of insulin (MI 
3000) elute (indicated as 2). These data clearly 
show that [1251]insulin was cross-linked to cu2M 
through a disulfide bond. It was calculated that 
each c~2M molecule carried 2-3 insulin moieties. 
We tested the binding of [1251]insulin-cY2M con- 
jugate to Swiss/3T3 cells and to a variant cell line, 
CI-3 [7]. The CI-3 cells possess only 10% of the pa- 
rental Swiss/3T3 cell’s insulin binding ability while 
they retain normal binding ability for ~u2M (fig.2). 
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Fig.2. Time course of [‘251](r2M and insulin binding to 
Swiss/3T3 and CI-3 cells. The confluent cultures were 
incubated with 2 nM [r2’I]02M (o), or 0.27 nM 
[‘251]insulin (0) at 23°C. Specific binding was 
determined by subtracting the binding in the presence of 
excess unlabelled a2M or insulin from the total binding. 
Fig.3. Time course of binding of [‘251]insulin-cr2M 
conjugate to Swiss/3T3 and CI-3 cells. The confluent 
cultures were incubated at 23°C with 1.6 nM conjugate 
(0). in the presence of excess (r2M (0) or insulin (A). 
Nonspecific binding was determined in the presence of 
excess insulin and a2M, and subtracted from the total 
binding. 
The binding kinetics of the insulin-cu2M conjugate 
at 23°C are shown in fig.3. Binding could have ta- 
ken place through two kinds of receptors: one for 
insulin and the other for (YAM. In fact, in 
Swiss/3T3 cells the addition of insulin or cu2M in 
excess decreased the binding of the insulin-cu2M 
conjugate to 50% and 44% of the control, respec- 
tively. In CI-3 cells, the addition of tu2M resulted 
in the marked reduction of cell-bound conjugate 
while the addition of insulin caused only a small 
decrease in binding. These results indicate that the 
insulin-cu2M conjugate is capable of binding both 
insulin receptors and a2M receptors and that pre- 
ferential binding to c~2M can be achieved by ad- 
ding excess insulin. 
Next, we examined whether the insulin-a2M 
conjugate is able to deliver the insulin into cells 
and if so how it is intracellularly processed. For 
this, 3T3 cells were incubated with the conjugate 
for 90 min at 23°C in the presence of excess insu- 
lin. Cells were then gently lysed, and the cell- 
associated radioactivity was analyzed by Percoll 
density gradient centrifugation (fig.4A). Under 
these conditions the majority of radioactivity was 
found in the plasma membrane fraction (Q = 
1.038) and the rest found in the fractions near the 
bottom of the gradient. If these cells were further 
incubated at 37”C, the radioactivity was transfer- 
red within 30 min to the bottom fractions. The 
bottom fractions include lysosomes. In the case of 
CI-3 cells (fig.4B), the radioactivity was distribu- 
ted in several fractions including the plasma mem- 
brane and lysosomes. The heterogeneous compo- 
nents of intermediate density in CI-3 are likely to 
be vesicles but at present have not been identified. 
By raising the temperature to 37”C, the conjugate 
almost completely shifted to the fractions at the 
bottom in both cell lines. The radioactivity recove- 
red from the Swiss/3T3 cells which had been trea- 
ted as in fig.4 are found to be mostly high molecu- 
lar weight conjugate form (fig.5). Taking all these 
results together we conclude that the insulin-a2M 
conjugate is internalized through the a2M receptor 
and intracellularly processed. 
4. DISCUSSION 
In this paper, insulin was cystaminylated and 
cross-linked to the cysteinyl residues of a2M via a 
disulfide bond. The hybrid molecule had binding 
capacity for both insulin receptors and a2M recep- 
tors. We were able to restrict the binding of the 
conjugate to either of these receptors by adding in- 
sulin or (YAM in excess. The binding of the 
insulin-a2M conjugate to CI-3 cells, which pos- 
sess a greatly reduced insulin binding capacity, was 
predominantly mediated through the a2M recep- 
tor. We also demonstrated that the conjugate 
bound to the a2M receptor was internalized and 
delivered to lysosome-like intracellular organelles. 
Recently, Roth et al. [12] produced a conjugate 
by cross-linking insulin to the binding subunit of 
ricin (RICb). They demonstrated that the binding 
of insulin-RICb conjugate to rat hepatoma HTC 
cells occurred predominantly via the ricin B chain 
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Fig.4. Percoll density gradient analysis of subcellular localization of [ 1251]insulin-cu2M conjugate. Confluent cultures 
were incubated at 23°C with 0.5 nM [ *ZSI]insulin-cu2M conjugate in 8 ml of binding buffer containing 1% BSA for 
90 min. They were then rinsed and processed for Percoll gradient analysis (-+-). Identically treated cells were further 
incubated at 37°C in DME-medium containing 10% FCS for 30 min and processed for Percoll analysis (+). L, G, 
PM, and ER denote the position of lysosomes, Golgi, plasma membranes and endoplasmic reticulum, respectively. The 
position of PM in the gradient was determined by binding of [ 1251]~2M at 4°C at which temperature cu2M binds to the 
plasma membrane but is not internalized. A density curve (-u-) was determined from refractive index of the gradient 
fractions. 
FRACTION 
Fig.5. Chromatographic analysis of cell bound 
[‘Z51]insulin-cY2M conjugate. Swiss/3T3 cells were 
treated with [1251]insulin-ru2M conjugate at 23°C for 
90 min, washed, and the temperature was shifted to 
37°C as in fig.4. At 0 (0) and 30 min (0) after the 
temperature shift, the cells were dissolved in 4 M 
urea/l M acetic acid/O. 1% Triton X-100 and analyzed 
on a column of Sephadex G-75. VO, void volume. 
portion of the conjugate. In the same cells, the 
conjugate mimicked insulin-like biological activi- 
ties. However, no data were presented to clarify 
whether the conjugate was internalized and in- 
tracellularly processed to induce such stimulatory 
effects on the cellular metabolism. The use of 
RICb for insulin delivery is disadvantageous since 
insulin and ricin may be transported by separate 
pathways [13,14]. Utilization of cu2M is advan- 
tageous because it is known that a2M is bound to 
rather ubiquitous receptors and internalized in a 
manner similar to insulin [15]. If our insulin-cu2M 
conjugate is able to produce insulin-stimulated ef- 
fects in cells, it may be beneficial in the treatment 
of those diseases which have insulin receptor defi- 
ciencies. The utilization of human serum proteins 
such as (YAM will cause no immunological or 
pathological problems. Moreover, these hybrid in- 
sulin molecules would be useful in studying the 
mechanism of insulin action, particularly to test 
whether cell surface insulin receptors are essential 
for activities of insulin. 
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In preliminary experiments using a denser Per- 
co11 gradient, there was clear separation of vesicles 
containing the conjugate from the lysosomes in 
both 3T3 and CI-3 cells. Furthermore, large porti- 
ons of the conjugate remained in the lysosome-like 
dense vesicles in a high molecular weight form. In- 
terestingly, Khan et al. 1161 have recently reported 
that endocytosed insulin is found in Golgi elements 
and in unique vesicles having lysosome-like featu- 
res. The unique vesicles are similar to, if not identi- 
cal with, the lysosome-like vesicles carrying the in- 
ternalized ~2~-insulin conjugate described here. 
The biological significance of these vesicles is un- 
der investigation, particularly with respect to the 
possible role of internalized insulin. 
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